In Silico Analysis of Active Constituents of Silymarin as Αlpha-Glucosidase Enzyme Inhibitors in Type 2 Diabetes Mellitus

Abstract

Objective: Type 2 diabetes mellitus (T2DM) is an acute metabolic disorder, in which the vogue is increasing persistently globally. The maltase-glucoamylase/alpha-glucosidase inhibitor is an oral antidiabetic drug collectively, which is utilizing for regulating carbohydrates that ordinarily transformed into simple sugars and absorbed by the intestine. Researchers need to constantly explore alternative therapeutic strategies for the clinical management of DM due to the increased adverse event caused by conservative antidiabetic agents. The present study proposes a substitute drug to examine the seven bioactive phytocomponents of Silybum marianum (milk thistle) that can regulate the hyperglycemia by downregulating alpha-glucosidase and its activity.
 Methods: Different integrated web-based in silico tools and techniques were used to model the enzyme (receptor) as well as to determine the druggability of different active constituents of silymarin and their pharmacokinetics were predicted. Further, the active site of the enzyme was predicted followed by molecular docking method.
 Results: The results show silychristin A and silydianin having less carcinogenicity and strong interaction to the target protein (alpha-glucosidase) compare to the reference drugs (acarbose and miglitol) and these two molecules can be used for the best drug molecules in T2DM.
 Conclusion: In the proposed study, the in silico analysis helps researchers to utilize these compounds for clinical applications. The conclusion also suggests that synthetically and semi-synthetically, nucleus and peripheral modifications, either in the form of skeletal rearrangements or partial degradations as well as functional group addition and replacement of the active molecules present in silymarin giving access to new structural motifs, which can be used in future as a lead compounds for antagonising the alpha-glucosidase in the treatment of diabetes mellitus.

In-Silico Study of Silymarin Against Spike Glycoprotein of Coronavirus

“…In-silico study of Silymarin ligand and 5XLR protein using computational tools show the binding energies and amino acid of protein interacting with ligand Silymarin [15] .…”

In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone Helichrysum petiolare Extract (AAHPE) with Molecular Docking Relevance in Diabetes Mellitus

“…In view of this, the drugs formulated using these bioactive compounds that fulfilled Lipinski’s rule of five may have some significant advantages over the synthetic compound (acarbose). Interestingly, acarbose violated three out of the five rules and has been reported to be metabolically unstable [ 53 , 54 ].…”

Asymmetric Membranes: A Potential Scaffold for Wound Healing Applications

“…As is known, the presence of bacteria around the wound can delay or discontinue the process of wound healing and even this colonization by bacteria may endanger human life [58,59]. Hence, wound dressing or the presence of antibacterial agents [60][61][62][63][64][65] can control the growth of bacteria and it is the main property of asymmetric membranes. For example, Mousavi et al in their review about gold nanostars have stated that these multi-branch materials can rupture the external membrane of bacteria and provide extraordinary antibacterial effects [66].…”